Meddenovo Drug Design
PrivateLast Round
Pre Seed
Jul 31, 2024
Total Funding Raised
$1.08M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Meddenovo Drug Design operates in Healthcare & Life Sciences and is based in Villeurbanne. Its latest recorded funding round was a Pre Seed round in July 2024.
Meddenovo Drug Design is a biotechnology company that develops an AI-powered platform for the de novo design of cyclic peptides to accelerate drug discovery.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Subscription SaaS, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Meddenovo Drug Design Comparables
Compare Meddenovo Drug Design with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cyclic Therapeutics AB | 89% | |
| ProteinQure | 83% | |
| Receptor.AI | 81% |
For institutional investors. Book with your work email.
Meddenovo Drug Design Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Meddenovo Drug Design Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| ACT Venture Partners | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors grew 87% MoM.
- Jun 24, 2026
Monthly visitors grew 879% MoM, from 28 to 274.
For institutional investors. Book with your work email.
Meddenovo Drug Design Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Meddenovo Drug Design's valuation, stock price, and market status.
Is Meddenovo Drug Design a public or private company?
Meddenovo Drug Design is a private company.
What is the current stock price of Meddenovo Drug Design?
Meddenovo Drug Design is a private company, so its shares have no public market price. Caplight tracks Meddenovo Drug Design's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Meddenovo Drug Design worth (valuation)?
Valuation information for Meddenovo Drug Design is not publicly available.
Can I buy Meddenovo Drug Design stock?
Meddenovo Drug Design shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Meddenovo Drug Design's last funding round?
Meddenovo Drug Design's most recent funding round was Pre Seed on July 31, 2024.
Who are the main investors in Meddenovo Drug Design?
Key investors in Meddenovo Drug Design include ACT Venture Partners.
Will Meddenovo Drug Design IPO soon?
No public IPO plans have been announced for Meddenovo Drug Design.
How can I track Meddenovo Drug Design secondary market activity?
Caplight tracks bids, offers, and trades in Meddenovo Drug Design's shares on secondary markets.